Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients

BACKGROUND: High grade serous ovarian cancer (HGSOC) is the most common subtype of ovarian cancer. Although platinum-based chemotherapy has been the cornerstone for HGSOC treatment, nearly 25% of patients would have less than 6 months of interval since the last platinum chemotherapy, referred to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Zhang, Xiaolan, Gao, Yan, Shang, Chunliang, Yu, Bo, Wang, Tongxia, Su, Junyan, Huang, Cuiyu, Wu, Yu, Guo, Hongyan, Ha, Chunfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977004/
https://www.ncbi.nlm.nih.gov/pubmed/33747898
http://dx.doi.org/10.3389/fonc.2020.625866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977004/
https://www.ncbi.nlm.nih.gov/pubmed/33747898
http://dx.doi.org/10.3389/fonc.2020.625866

Ejemplares similares